35022128|t|Narcolepsy-like symptoms triggered by lemborexant in the context of hyperactive delirium in a patient with bipolar depression: a case report.
35022128|a|Lemborexant is a dual orexin antagonist and is considered a safe and effective hypnotic. Dual orexin antagonists induce physiological sleep by blocking orexin receptors. Although the blockade of orexin signaling has triggered narcolepsy-like symptoms in rodents, there is currently no evidence of lemborexant inducing narcolepsy-like symptoms in humans. We describe the case of a 79-year-old Japanese woman with bipolar depression who experienced lemborexant-induced cataplexy and sleep attack. Her previous results on the Multiple Sleep Latency Test excluded the diagnosis of narcolepsy. She experienced narcolepsy-like symptoms on 2 occasions after she was administered lemborexant, in the context of hyperactive delirium, but not in a relaxed state. Her case suggests that lemborexant could trigger narcolepsy-like symptoms in patients with hyperactive delirium, even those with no history of narcolepsy. This case also emphasizes that clinicians must be very careful when they prescribe lemborexant to patients who experience hyperactive delirium. CITATION: Shibata S, Oda Y, Ohki N, et al. Narcolepsy-like symptoms triggered by lemborexant in the context of hyperactive delirium in a patient with bipolar depression: a case report. J Clin Sleep Med. 2022;18(5):1459-1462.
35022128	0	24	Narcolepsy-like symptoms	Disease	MESH:D009290
35022128	38	49	lemborexant	Chemical	MESH:C000634104
35022128	68	88	hyperactive delirium	Disease	MESH:D003693
35022128	94	101	patient	Species	9606
35022128	107	125	bipolar depression	Disease	MESH:D001714
35022128	142	153	Lemborexant	Chemical	MESH:C000634104
35022128	164	170	orexin	Gene	3060
35022128	236	242	orexin	Gene	3060
35022128	337	343	orexin	Gene	3060
35022128	368	392	narcolepsy-like symptoms	Disease	MESH:D009290
35022128	439	450	lemborexant	Chemical	MESH:C000634104
35022128	460	484	narcolepsy-like symptoms	Disease	MESH:D009290
35022128	488	494	humans	Species	9606
35022128	543	548	woman	Species	9606
35022128	554	572	bipolar depression	Disease	MESH:D001714
35022128	589	600	lemborexant	Chemical	MESH:C000634104
35022128	609	618	cataplexy	Disease	MESH:D002385
35022128	623	635	sleep attack	Disease	MESH:D012893
35022128	719	729	narcolepsy	Disease	MESH:D009290
35022128	747	771	narcolepsy-like symptoms	Disease	MESH:D009290
35022128	814	825	lemborexant	Chemical	MESH:C000634104
35022128	845	865	hyperactive delirium	Disease	MESH:D003693
35022128	918	929	lemborexant	Chemical	MESH:C000634104
35022128	944	968	narcolepsy-like symptoms	Disease	MESH:D009290
35022128	972	980	patients	Species	9606
35022128	986	1006	hyperactive delirium	Disease	MESH:D003693
35022128	1038	1048	narcolepsy	Disease	MESH:D009290
35022128	1133	1144	lemborexant	Chemical	MESH:C000634104
35022128	1148	1156	patients	Species	9606
35022128	1172	1192	hyperactive delirium	Disease	MESH:D003693
35022128	1237	1261	Narcolepsy-like symptoms	Disease	MESH:D009290
35022128	1275	1286	lemborexant	Chemical	MESH:C000634104
35022128	1305	1325	hyperactive delirium	Disease	MESH:D003693
35022128	1331	1338	patient	Species	9606
35022128	1344	1362	bipolar depression	Disease	MESH:D001714
35022128	Positive_Correlation	MESH:C000634104	MESH:D009290
35022128	Positive_Correlation	MESH:C000634104	MESH:D012893
35022128	Positive_Correlation	MESH:C000634104	MESH:D002385
35022128	Negative_Correlation	MESH:C000634104	3060
35022128	Negative_Correlation	MESH:C000634104	MESH:D003693

